121 related articles for article (PubMed ID: 3935372)
1. Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.
Holma P; Robertson DN
Contraception; 1985 Aug; 32(2):163-71. PubMed ID: 3935372
[TBL] [Abstract][Full Text] [Related]
2. First year clinical experience with six levonorgestrel rods as subdermal contraception.
Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel plasma levels during continuous administration with different models of subdermal implants.
Alvarez F; Brache V; Faundes A; Johansson ED; Odlind V; Nash H
Contraception; 1983 Feb; 27(2):123-30. PubMed ID: 6406138
[TBL] [Abstract][Full Text] [Related]
4. The effects of Implanon on lipid metabolism in comparison with Norplant.
Suherman SK; Affandi B; Korver T
Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2).
Olsson SE; Odlind V; Johansson ED; Nordström ML
Contraception; 1987 Mar; 35(3):215-28. PubMed ID: 3111784
[TBL] [Abstract][Full Text] [Related]
6. Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment.
Haukkamaa M
Contraception; 1986 Jun; 33(6):559-65. PubMed ID: 3095023
[TBL] [Abstract][Full Text] [Related]
7. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
8. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
Singh K; Ratnam SS
Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
[TBL] [Abstract][Full Text] [Related]
9. Androgen levels in women using Norplant implants.
Olsson SE; Odlind V; Johansson E
Contraception; 1986 Aug; 34(2):157-67. PubMed ID: 2946553
[TBL] [Abstract][Full Text] [Related]
10. Norplant contraceptive implants: rods versus capsules.
Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
Dash DS; Das S; Nanda U; Tripathy BB; Samal KC
Contraception; 1988 Apr; 37(4):371-82. PubMed ID: 3133159
[TBL] [Abstract][Full Text] [Related]
12. A new delivery system for contraceptive steroids.
Segal S
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
[TBL] [Abstract][Full Text] [Related]
13. Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel.
Croxatto HB; Díaz S; Brandeis A; Pavez M; Johansson ED
Contraception; 1985 Jun; 31(6):643-54. PubMed ID: 3930143
[TBL] [Abstract][Full Text] [Related]
14. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
15. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
Shaaban MM; Elwan SI; Abdalla SA; Darwish HA
Contraception; 1984 Nov; 30(5):413-9. PubMed ID: 6440737
[TBL] [Abstract][Full Text] [Related]
16. Long-term reversible contraception with levonorgestrel-releasing Silastic rods.
Roy S; Mishell DR; Robertson DN; Krauss RM; Lacarra M; Duda MJ
Am J Obstet Gynecol; 1984 Apr; 148(7):1006-13. PubMed ID: 6424474
[TBL] [Abstract][Full Text] [Related]
17. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
18. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins.
Otubu JA; Towobola OA; Aisien AO; Ogunkeye OO
Contraception; 1993 Feb; 47(2):149-59. PubMed ID: 8449015
[TBL] [Abstract][Full Text] [Related]
19. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
20. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]